Health Topics Pharma News
Pharma News
FDA Approval Activities for this Drug Neutrexin (trimetrexate glucuronate) Injection, 25 mg, 200 mg, MedImmune Oncology, NDA 20-326/S-011, S-013
Neutrexin (trimetrexate glucuronate) Injection, 25 mg, 200 mg, MedImmune Oncology, NDA 20-326/S-011, S-013
For the latest approval information and links for this API, please see the main page.